Meta facebook tracking pixel

Listen Now

Topics Covered

  • Review of the Treatments of Polycythemia Vera (PV), Essential Thrombocythemia (ET) & Myelofibrosis (MF) & Common Treatment Side Effects
  • Reducing Complications of Myeloproliferative Neoplasms (MPNs): What You Need to Know & Do
  • Key Concerns to Discuss with Your Doctor & Health Care Team, Including Treatment Side Effects & Symptoms Requiring Immediate Attention Between Appointments
  • Keeping a Journal of Specific Side Effects, Symptoms, Discomfort & Pain to Report to Your Doctor
  • Know the Warning Signs of a Potential Medical Emergency & What to Do
  • How Being More Assertive May Improve Your Care & Quality of Life
  • Questions to Ask Our Panel of Experts

Our Panel of Experts


Aaron T. Gerds, MD, MS

Associate Professor of Medicine, Hematology & Medical Oncology, Deputy Director for Clinical Research, Cleveland Clinic Taussig Cancer Institute, Medical Director, Case Comprehensive Cancer Center Clinical Research Office, Principal Investigator, Case Lead Academic Participating Site


Prithviraj Bose, MD

Professor, Department of Leukemia, University of Texas MD Anderson Cancer Center


Krisstina L. Gowin, DO

Associate Professor of Medicine, Division of Hematology and Oncology, Program Director, Hematology Oncology Fellowship Program, Founder/Director, Integrative Medicine in Hematology Oncology Fellowship University of Arizona, University of Arizona College of Medicine, Tucson, Arizona


Carolyn Messner, DSW, BCD, FAPOS, FAOSW

Senior Director of Education and Training, CancerCare


You can download the brochure for this workshop Download button

Workshop Date

This workshop was originally recorded on February 28, 2024.

Search by:



The information presented in this workshop is provided for your general information only. It is not intended as medical advice and should not be relied upon as a substitute for consultations with qualified health professionals who are aware of your specific situation. We encourage you to take information and questions back to your individual health care provider as a way of creating a dialogue and partnership about your cancer and your treatment.

Back to Top

Terms of Use and Privacy Policy

By using our website, you agree to our recently updated Privacy Policy . Here you can read more about our use of cookies which help us make continuous improvements to our website. Privacy Policy.